BRITISH CANNABIS™ Becomes the UK’s Most Prescribed Medical Cannabis Oil Brand

In a major development for the UK’s evolving medical cannabis sector, BRITISH CANNABIS™ has now become the most prescribed cannabis oil brand in the country — marking a significant step forward for clinicians and patients seeking more consistent, personalised treatment options.

This milestone reflects a broader shift in the UK’s approach to cannabis-based prescription medicines, as doctors increasingly seek out formulations that offer clarity, reliability, and therapeutic versatility.

A New Standard in Cannabis-Based Medicines

At the core of BRITISH CANNABIS™’s success is a uniquely structured range of strain-specific oils, designed to make prescribing and patient care simpler and more effective.

The brand’s oils are available in two core formats — 2THC™ and 5THC™ — giving clinicians a clear framework for precision dosing in line with titration protocols. Each product pairs THC with CBD and is supported by detailed terpene profiles tailored to symptom clusters such as chronic pain, sleep disruption, inflammation, and anxiety.

Additionally, the company’s 5CBD™ range — featuring identical terpene profiles without any THC — offers a flexible alternative when THC is not clinically appropriate, or when it’s used in combination with lower doses. This mirrored formulation strategy enables a smooth transition between THC-containing and THC-free products without sacrificing consistency.

Strain-Specific. Terpene-Led. UK-Made.

What sets the BRITISH CANNABIS™ range apart is its commitment to full-plant, terpene-led medicine — an approach rarely seen at this scale in the UK market.

•Each oil is derived from full-spectrum extracts, preserving the full entourage of cannabinoids and terpenes for maximum therapeutic effect.

•Every batch is manufactured in the UK, rigorously lab-tested, and certified to ensure safety and transparency.

•The entire range is built around real-world patient needs, with eight distinct strains tailored to specific conditions, rather than generic cannabinoid blends.

This model of personalised, terpene-specific cannabis medicine represents the next evolution of prescribing in the UK — and BRITISH CANNABIS™ appears to be leading the charge.

The Rise of 5CBD™

Outside of prescription channels, 5CBD™ is already available as a consumer product — with the same eight terpene profiles used across the THC range. Prescription access is expected to follow shortly, offering doctors and patients yet another tool in the expanding medical cannabis toolkit.

Whether used alone or in combination with THC oils, 5CBD™ offers a reliable, UK-made option for cannabinoid therapy with no psychoactive effects.

Why This Milestone Matters

Becoming the most prescribed cannabis oil brand in the UK is more than a commercial achievement. It signals a wider movement toward patient-first prescribing, where medical cannabis is no longer limited to generic or one-size-fits-all products.

It also reflects growing confidence among doctors — many of whom are now choosing BRITISH CANNABIS™ oils as a foundation for safe, controlled, and personalised cannabinoid treatment.

As the UK’s regulatory and clinical landscape continues to evolve, BRITISH CANNABIS™ is positioned not just as a market leader, but as a blueprint for what responsible, effective cannabis-based medicine should look like.